New imaging tool may predict breast cancer treatment response early
NCT ID NCT03822312
First seen Apr 14, 2026 · Last updated May 15, 2026 · Updated 2 times
Summary
This study tests whether a new type of breast scan (DBT-TOBI) can predict how well chemotherapy works in women with certain breast cancers. About 30 participants will get scans before and during treatment to see if early changes in blood flow can tell doctors if the cancer will fully respond. The goal is to improve monitoring and avoid unnecessary treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.